We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$24B
AUM Growth
+$2.89B
Cap. Flow
+$2.75B
Cap. Flow %
11.43%
Top 10 Hldgs %
10.27%
Holding
2,691
New
770
Increased
420
Reduced
344
Closed
817

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Financials 12.61%
3 Industrials 10.64%
4 Consumer Discretionary 9.75%
5 Healthcare 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIA.U
876
DELISTED
GigCapital 5, Inc. Units, each consisting of one share of common stock and one whole redeemable warrant
GIA.U
$4.11M 0.02%
+400,000
New +$4.09M
MLCO icon
877
Melco Resorts & Entertainment
MLCO
$2.08B
$4.09M 0.02%
399,613
+259,215
+185% +$3.41M
LEAP
878
DELISTED
Ribbit LEAP, Ltd.
LEAP
$4.08M 0.02%
403,034
-2,266
-0.6% -$23.3K
MMSI icon
879
Merit Medical Systems
MMSI
$5.39B
$4.07M 0.02%
56,639
-208,232
-79% -$14.1M
AHPAU
880
DELISTED
Avista Public Acquisition Corp. II Unit
AHPAU
$4.06M 0.02%
+400,000
New +$4.02M
DCRDU
881
DELISTED
Decarbonization Plus Acquisition Corporation IV Unit
DCRDU
$4.05M 0.02%
+400,000
New +$4.02M
PTCT icon
882
PTC Therapeutics
PTCT
$5.93B
$4.03M 0.02%
108,292
-136,540
-56% -$5.61M
DOC
883
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4.01M 0.02%
+227,626
New +$4.21M
ENJY
884
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$4M 0.02%
400,000
RACE icon
885
Ferrari
RACE
$74.6B
$3.99M 0.02%
+19,099
New +$4.1M
APR
886
DELISTED
Apria, Inc. Common Stock
APR
$3.98M 0.02%
107,117
+87,269
+440% +$2.87M
FOSL icon
887
Fossil Group
FOSL
$329M
$3.98M 0.02%
335,576
+32,562
+11% +$421K
LDTC
888
DELISTED
LeddarTech
LDTC
$3.97M 0.02%
814,002
PACX
889
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$3.97M 0.02%
400,000
GRNA
890
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$3.96M 0.02%
400,000
TRIL
891
DELISTED
Trillium Therapeutics Inc.
TRIL
$3.95M 0.02%
+225,000
New +$2.63M
PMGM
892
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$3.94M 0.02%
400,000
OSI
893
DELISTED
Osiris Acquisition Corp.
OSI
$3.93M 0.02%
+400,000
New +$3.86M
HRMY icon
894
Harmony Biosciences
HRMY
$2.24B
$3.92M 0.02%
+102,292
New +$3.29M
OWLT icon
895
Owlet
OWLT
$148M
$3.91M 0.02%
+50,000
New +$5.59M
EPWR
896
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$3.91M 0.02%
400,000
ENOV icon
897
PUT
Enovis
ENOV
$1.45B
$3.9M 0.02%
+49,385
New +$3.97M
FVT
898
DELISTED
Fortress Value Acquisition Corp. III
FVT
$3.9M 0.02%
400,000
AVTA
899
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
$3.9M 0.02%
250,000
EVRG icon
900
Evergy
EVRG
$18.8B
$3.89M 0.02%
62,585
+52,132
+499% +$3.42M

Similar funds

Dmitry Balyasny's Q3 2021 Portfolio in Review

As of Q3 2021, Dmitry Balyasny held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Dmitry Balyasny deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.

  • Dmitry Balyasny's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
  • Dmitry Balyasny's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
  • Dmitry Balyasny fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
  • Dmitry Balyasny's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
  • Dmitry Balyasny opened 770 new positions and closed 817 in Q3 2021.
  • Dmitry Balyasny's portfolio value rose 14% quarter-over-quarter to $24B.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.